Neurobehavioral burden of multiple sclerosis with nanotheranostics
Bhasker Sriramoju, Rupinder K Kanwar, Jagat R Kanwar Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine, Molecular and Medical Research, Faculty of Health, Deakin University, VIC, Australia Abstract: Multiple sclerosis (MS) is a chronic demyelinati...
Enregistré dans:
Auteurs principaux: | Sriramoju B, Kanwar RK, Kanwar JR |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8061bea6a1dd4d9f9fd5bc99ab872cf6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis
par: Babij R, et autres
Publié: (2015) -
Association between smoking and cognitive impairment in multiple sclerosis
par: Özcan ME, et autres
Publié: (2014) -
Cognitive dysfunction in pediatric multiple sclerosis
par: Suppiej A, et autres
Publié: (2014) -
The Multiple Sclerosis Treatment Optimization Program
par: Annette Langer‐Gould, et autres
Publié: (2021) -
Role of oral teriflunomide in the management of multiple sclerosis
par: Tanasescu R, et autres
Publié: (2013)